Our Product Pipeline
From initial research through to scale-up manufacturing, we are focused on providing the highest quality reagents for human health, facilitating cutting-edge research and delivering real improvements to assay performance.
Antigens
Design and Cloning
In silico design of optimal protein sequences and cloning into optimised vectors.
Expression Testing
Feasibility of expression in a range of constructs and systems to select for optimal conditions.
Purification and Scale-Up
Determination of optimal purification methods to maximise purity and yield before scale-up.
- African Swine Fever Virus p32
- Borrelia burgdorferi OspA
- Borrelia burgdorferi OspB
- Borrelia burgdorferi OspC
- Hepatitis A Virus VP0-VP3-VP1 Polyprotein
- Hepatitis C Virus Capsid Protein
- Influenza Virus-Like Particles
- Mumps Virus-Like Particles
- Borrelia burgdorferi VlsE
- Norovirus GI.2 VP1
- Norovirus GI.4 VP1
- Norovirus GII.3 VP1
- Norovirus GII.8 VP1
- Norovirus GII.13 VP1
Disease Markers & Receptors
Design and Cloning
In silico design of optimal protein sequences and cloning into optimised vectors.
Expression Testing
Feasibility of expression in a range of constructs and systems to select for optimal conditions.
Purification and Scale-Up
Determination of optimal purification methods to maximise purity and yield before scale-up.
- Human Neuropilin-1 (NRP-1)
- Human Dipeptidylpeptidase 4
- Human Procalcitonin
- Human Troponin Tnl
Antibodies
Generation
Generation with immunogen in a range of animal models.
Screening
Screening of animals and hybridomas for high affinity targets.
Purification
Determination of optimal purification methods to maximise purity and yield before scale-up.
- Norovirus VLP Monoclonals
- Norovirus VLP Polyclonals
- Rubella VLP Monoclonals